Identifying Undiagnosed Nonvalvular Atrial Fibrillation in the Age of Telehealth: Novel Screening Technologies and Stroke Prevention Strategies
An Interactive Webinar
Novel digital tools hold promise in identifying AF—the first step in preventing stroke. Join experts Dr. Ruff and Dr. Turakhia for this timely interactive webinar as they provide tips on how to identify and manage this serious condition promptly and consistently per the latest tools and evidence, with a focus on risk assessment and shared decision-making to determine what type of oral anticoagulation is needed, if any, once AF is detected.
Faculty
Christian T. Ruff, MD, MPH
Director, General Cardiology
Brigham and Women’s Hospital
Harvard Medical School
TIMI Study Group
Boston, MA
Mintu Turakhia, MD, MS
Associate Professor of Medicine
Executive Director, Center for Digital Health
Cardiac Electrophysiology Section
Stanford University School of Medicine
Stanford, CA
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize the high clinical impact of atrial fibrillation (AF), including the risk of stroke
- Implement evidence-based in-office and telehealth strategies for identification of undiagnosed AF
- Individualize oral anticoagulation decisions regarding stroke prevention in patients with nonvalvular AF (NVAF) based on guideline-recommended risk assessment, patient characteristics, and current evidence
Target Audience
This activity has been designed to address the educational needs of cardiologists, interventional cardiologists, primary care providers, allied healthcare professionals (ie, nurse practitioners, PAs, and pharmacists), and other clinicians involved in the care of patients with cardiovascular disease.
Identifying Undiagnosed Nonvalvular Atrial Fibrillation in the Age of Telehealth: Novel Screening Technologies and Stroke Prevention Strategies
